Diagnostic value of a combined C-reactive protein and haptoglobin tests in new cases of upper tract urothelial carcinoma (original) (raw)

Prostate cancer immunology - an update for Urologists

Damien Bolton

BJU International, 2011

View PDFchevron_right

Macroscopic haematuria and urological cancer

Raj Persad

The British journal of general practice : the journal of the Royal College of General Practitioners, 2003

View PDFchevron_right

Handling and Staging of Renal Cell Carcinoma

Masoud Ganji

American Journal of Surgical Pathology, 2013

View PDFchevron_right

Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: Clinical and epidemiological implications

Umberto Maggiore

Journal of Laboratory and Clinical Medicine, 2005

View PDFchevron_right

Guidelines for development of diagnostic markers in bladder cancer

Peter Goebell

World Journal of Urology, 2008

View PDFchevron_right

Novel aspects of clinical and pathological prognostic markers of urinary bladder and kidney cancers

János Révész

View PDFchevron_right

Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings

Yoshihisa Matsumoto

Journal of Pain and Symptom Management, 2016

View PDFchevron_right

Multiple Primary Malignancies in Renal Cell Carcinoma

Paul Russo

The Journal of Urology, 1998

View PDFchevron_right

Prognostic Value of the Involvement of the Urinary Collecting System in Renal Cell Carcinoma

Roberto Mario Scarpa

European Urology, 2004

View PDFchevron_right

Isolated Gross Hematuria or Associated to Acute Retention of Urine as a Sign of Urologic Malignant Pathology

Ambar Deschamps Perdomo

J. of Health Science, 2014

View PDFchevron_right

Newer diagnostic methods in oncology

purvish parikh

Medical Journal Armed Forces India, 2006

View PDFchevron_right

Cancer and renal insufficiency results of the BIRMA study

Joëlle Nortier

2010

View PDFchevron_right

Kidney Cancer, Version 3.2015

Steven Hancock

View PDFchevron_right

Clear Cell Papillary Renal Cell Carcinoma

Isabel Cabrero

The American Journal of Surgical Pathology, 2008

View PDFchevron_right

Urine and Serum Cathepsin B Concentrations in the Transitional Cell Carcinoma of the Bladder

Prusa Richard

Journal of Clinical Laboratory Analysis, 2012

View PDFchevron_right

Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need

Yee Mun Lee

Current Treatment Options in Oncology, 2019

View PDFchevron_right

Preoperative C-Reactive Protein in the Serum: A Prognostic Biomarker for Upper Urinary Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

Arnulf Stenzl

Urologia Internationalis, 2014

View PDFchevron_right

Urinary Markers in Bladder Cancer: An Update

Maria Morelli

Frontiers in Oncology, 2018

View PDFchevron_right

Circulating C-Reactive Protein Concentrations and Risks of Colon and Rectal Cancer: A Nested Case-Control Study Within the European Prospective Investigation into Cancer and Nutrition

Catalina Bonet

American Journal of Epidemiology, 2010

View PDFchevron_right

Screening History in 313 Cases of Invasive Cancer

Maggie Sun

Journal of Lower Genital Tract Disease, 2017

View PDFchevron_right

Diagnostic Criteria and LI‐RADS for Hepatocellular Carcinoma

Noah Walker

Clinical Liver Disease, 2021

View PDFchevron_right

Human" C-Reactive Protein (CRP) 1919 A/T" Polymorphism in Patients with Breast Cancer

zafir ghali

2017

View PDFchevron_right

Study of serum prostate specific antigen levels in patients with prostate lesions

DrashtI Shukla

International Journal of Clinical and Diagnostic Pathology, 2021

View PDFchevron_right

Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer

Abdullah Alghamdi

Urology Annals, 2014

View PDFchevron_right

Renal cell carcinoma: case report and literature review

l hakan güney

Journal of Pediatric Surgery, 2005

View PDFchevron_right